Drug and Diagnostic Test Notices

There is currently a national shortage of:
National shortages that have resolved:

For information on all current and resolved drug shortages and discontinuations reported to the U.S. Food & Drug Administration (FDA), please visit the FDA’s Drug Shortages pageexternal icon.

Diagnostic Information
  • STI Diagnotic Test Kits and Laboratory Suppliespdf icon (September 8, 2020)
    • UPDATE (November 24, 2020)
      CDC DSTDP has received recent reports from CDC-funded STD programs, as well as public/private laboratories that some STI diagnostic testing supplies are becoming more readily available, but often at lower-than-normal order levels. DSTDP has also received reports from CDC-funded STD programs that are still experiencing some shortages of  STI diagnostic testing supplies. Manufacturers are reporting ongoing efforts to increase production and release of product. However, the COVID-19 pandemic continues to impact the supply chain. A projected date for supplies to return to normal levels is unclear at this time. CDC’s Division of STD Prevention will continue to work with partners to address the availability of STI diagnostic testing supplies in the United States. In the interim, the CDC Dear Colleague Letter released on September 8, 2020 (above) provides guidance for prioritizing STI testing in the situation of diagnostic test shortages.